A phase 2b/3b MenACWY-TT study of long-term antibody persistence after primary vaccination and immunogenicity and safety of a booster dose in individuals aged 11 through 55 years

BACKGROUND: A previous phase 2 study demonstrated the immunogenicity of a single dose of meningococcal A, C, W, Y-tetanus toxoid conjugate (MenACWY-TT) or polysaccharide (MenACWY-PS) vaccine for up to 5 years in individuals aged 11–55 years. This follow-up study evaluated long-term antibody persiste...

Descripción completa

Detalles Bibliográficos
Autores principales: Borja-Tabora, Charissa Fay Corazon, Peyrani, Paula, Webber, Chris, Van der Wielen, Marie, Cheuvart, Brigitte, De Schrevel, Nathalie, Bianco, Veronique, Aris, Emmanuel, Cutler, Mark, Li, Ping, Perez, John L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301505/
https://www.ncbi.nlm.nih.gov/pubmed/32552685
http://dx.doi.org/10.1186/s12879-020-05104-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301505/
https://www.ncbi.nlm.nih.gov/pubmed/32552685
http://dx.doi.org/10.1186/s12879-020-05104-5

Ejemplares similares